Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 277 of 640

Advanced search

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Oculis buys out privosegtor’s global rights from Accure

Glance by Eyes On EyecareOriginal source

🇨🇦Aug 12Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 12Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Adequan I.M: Presence of particulate matter

Presence of particulate matter in affected lot.

Health Canada Recalls and Safety AlertsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Recruit Holdings Stock And 2 Japan Shares Backed By Strong Cash Flow

simplywall.stOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Oppenheimer Downgrades Legend Biotech to Perform From Outperform

marketscreener.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

TradingViewOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Trump’s tariffs plan threatens India’s ‘pharmacy of the world’ status

scmp.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

CTT Pharmaceutical Holdings (CTTH) secures U.S. patent for nicotine, vitamin and caffeine delivery

Stock TitanOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Biotech entrepreneur Mati Gil joins Naftali Bennett's 'Yachad' party

YnetnewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Ohio State launches AI-enabled biotech initiative to speed drug discovery

Ohio Tech NewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates

The Manila TimesOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

TScan Therapeutics Reports First Patient Dosed in Phase 3 ALLOHA-2 Study and Second-Quarter 2026 Results

Quiver QuantitativeOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Two Can-Fite Oral Drugs Advance in Phase III for Cancer, Psoriasis

Stock TitanOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

New Tufts CSDD Analysis Finds AI Agents Can Deliver Up to $21 Million in Net Financial Value Per Drug Development Program and Up to 82x ROI

Business WireOriginal source

🇺🇸Aug 12Devicesinvestors.bd.comTier 1 · Company source

BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial

Becton Dickinson (BD)Original source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies

STATOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Scaling Biotech Suspends Long-Form Blog Posts to Focus on Weekly Newsletter

geneonline.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

marketscreener.comOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Epicrispr, Vaderis secure pivotal study funding for rare disease assets

Pharmaceutical TechnologyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Misaligned Mental Models Between Wet Lab and Data Teams Hinder Biotech Data Integration

geneonline.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Scaling Biotech Established Consistent Publishing Schedule and Newsletter in 2021

geneonline.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Why is Legend Biotech stock sliding today?

Investing.comOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Fierce Biotech Layoff Tracker 2026: Aura loses 20% of staffers; aTyr shrinks by 60%

Fierce BiotechOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs

Fierce BiotechOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Trump signs order that nearly halves childhood immunisation coverage

Pharmaceutical TechnologyOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

AI brings savings to clinical trials: study

AxiosOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Snapchat Launches Ad Format for Pharmaceutical Regulatory Disclosures

geneonline.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

US Biotech Inocras Files for Kosdaq Tech-Special Listing, Initiating IPO Process

finance.biggo.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Annexon Launches Long-Term Extension for Vonaprument Trial

Stock TitanOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

The Next Race in Biologicals Isn't Innovation-It's Regulatory Strategy

AgrolatamOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

LOT Cargo secures IATA CEIV Pharma recertification

Aviation Business NewsOriginal source

🇺🇰Aug 12Researchukri.orgTier 2 · Direct publisher

STFC announces latest Ernest Rutherford Fellows

Medical Research Council (UKRI)Original source

🇺🇰Aug 12Researchmft.nhs.ukTier 2 · Direct publisher

Doctors highlight e-scooter safety risks after nearly 500 children are injured

Manchester University NHS Foundation TrustOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Fuso Pharmaceutical (TSE:4538) Stock Faces Margin Squeeze Despite Earnings Lift

simplywall.stOriginal source

🇺🇸Aug 12Industryinvestor.lilly.comTier 1 · Company source

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

Eli Lilly NewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Former Legend Biotech chief to lead newco builder K2 Therapeutics

The Pharma LetterOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Belite Bio lands priority review for first Stargardt treatment

The Pharma LetterOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Oman Offers Procurement, Pricing Incentives to Attract Pharmaceutical Investment

NAVLIN DAILYOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

CMG Pharmaceutical pursues reverse split to avert KOSDAQ delisting in Korea - CHOSUNBIZ

ChosunbizOriginal source

🇪🇸Aug 12Researchcrg.euTier 2 · Direct publisher

First 3D map of ovary throughout reproductive lifespan reveals it counts its own eggs

CRG Barcelona GenomicsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Pacer Advisors Inc. Sells 484,736 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Kwangdong Pharmaceutical Q2 Operating Profit 2.8 Billion Won, Down 38% From Year Earlier

TradingViewOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Zomato under the scanner after Zepto, Food Safety officials visit Bengaluru warehouses: Report

livemint.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

3 Japanese Stocks Trading Below Estimated Fair Value

simplywall.stOriginal source

🌍Aug 12Researchamref.orgTier 2 · Direct publisher

TOR: Training and Capacity Needs Assessment (T&CNA) FOR PARTNERSHIP FOR EDUCATION OF HEALTH PROFESSIONALS PROJECT

Amref Health AfricaOriginal source

🌍Aug 12discoverynews.google.comTier 2 · Trade media

Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say

STATOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Safety Questions Shadow Neurocrine's Rare-Disease Drug Vykat XR

streamlinefeed.co.keOriginal source

🇺🇰Aug 12Researchmedsci.ox.ac.ukTier 2 · Direct publisher

Arthritis origins may begin before birth, study finds

Oxford MedicineOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Inline Camera Inspection System Market for Food & Beverage and Pharmaceutical Industries by Component - Global Forecast to 2032

Yahoo Finance UKOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH

RTTNewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Swiss biotech Vaderis raises $152M to take first HHT-specific therapy into Phase 3

european-biotechnology.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

ChemoMetec gains “unique position” through Roche agreement, expects significant sales growth

medwatch.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) Stock Rebounds As Profit Arrives But Carvykti Risk Persists

simplywall.stOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cracks Down on Ayurvedic Drug Makers, Cancels 10 Licenses Over Major Violations

Republic WorldOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Key facts: NYSE:GS;Fees~40%2026;$152M biotech;Chandresh Chheda MD

TradingViewOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

RTW Biotech to Inject $6 Million in Avere Therapeutics Ahead of Reverse Merger

marketscreener.comOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) Returned To Profit, Is The Stock Still Cheap?

simplywall.stOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Karnataka’s Food Safety & Drug Administration directs hotels, dhabas, restaurants to strictly follow food safety & hygiene norms: J&K, FDA?

Cross Town NewsOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical (TSE:4502) Is Using AI To Advance Three Late Stage Medicines

simplywall.stOriginal source

🌍Aug 12discoverynews.google.comTier 3 · Aggregated media

Theriva Biologics reports $11.3M cash, 3-4 quarters runway for VCN-01 trial

The Clinical Trial VanguardOriginal source